J D Morgan1, T Horsburgh, A Simpson, P K Donnelly, P S Veitch, P R Bell. Show Affiliations » 1. Department of Surgery, Leicester General Hospital, United Kingdom.
Abstract
Entities: Disease
Mesh： See more » Cytomegalovirus Infections/drug therapyCytomegalovirus Infections/immunologyCytomegalovirus Infections/transmissionDose-Response Relationship, DrugGanciclovir/therapeutic useGraft Rejection/immunologyGraft Rejection/therapyHumansImmune Tolerance/drug effectsImmune Tolerance/immunologyKidney Function TestsKidney Transplantation/immunologyMuromonab-CD3/administration & dosageMuromonab-CD3/adverse effectsOpportunistic Infections/immunologyPostoperative Complications/immunologyPostoperative Complications/therapyTissue Donors
Substances： See more » Muromonab-CD3Ganciclovir
Year: 1992 PMID： 1334589
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066